Cargando…
Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics
Monoclonal antibody therapies have significantly improved treatment outcomes for patients with severe asthma; however, a significant disease burden remains. Available biologic treatments, including anti-immunoglobulin (Ig)E, anti-interleukin (IL)-5, anti-IL-5Rα and anti-IL-4Rα, reduce exacerbation r...
Autores principales: | Porsbjerg, Celeste M., Sverrild, Asger, Lloyd, Clare M., Menzies-Gow, Andrew N., Bel, Elisabeth H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676874/ https://www.ncbi.nlm.nih.gov/pubmed/32586879 http://dx.doi.org/10.1183/13993003.00260-2020 |
Ejemplares similares
-
The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations
por: Sverrild, Asger, et al.
Publicado: (2021) -
Missing sputum samples are common in asthma intervention studies and successful collection at follow-up is related to improvement in clinical outcomes
por: Frøssing, Laurits, et al.
Publicado: (2021) -
Mucosal cryobiopsies: a new method for studying airway pathology in asthma
por: Hvidtfeldt, Morten, et al.
Publicado: (2022) -
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
por: Nieto-Fontarigo, Juan José, et al.
Publicado: (2021) -
Diagnostic work-up in patients with possible asthma referred to a university hospital
por: Backer, Vibeke, et al.
Publicado: (2015)